Bob Pinedo, MD, PhD, a Professor Emeritus of the VU University Medical Center (VUmc), and a consultant to the Board of the VUmc Cancer Center, Amsterdam, the Netherlands has been awarded by the ASCO David A. Karnofsky Memorial Award.[1]
As a clinical investigator taking new concepts into early clinical trials, Pinedo has made seminal observations in cancer biology and treatment-related mechanisms of drug action and resistance in the patient.
Pinedo first began studying medicine in Leiden in 1960. He later specialized in internal medicine and in 1972 he began to focus specifically on the management and care of patients with cancer. Commenting on his early days, Pinedo said: “I had just got my PhD and had been appointed specialist registrar for Internal Medicine at Utrecht University Hospital. There were many cancer patients in my ward. Surgery was not possible for some of them and there were simply no treatment options left at all. We could not do anything for them.”
In 1979, Pinedo was appointed as Professor of Oncology and head of department at VUmc. At the same time he was given responsibility for the pharmacological laboratory at the Dutch Cancer Institute.
Over the years, Pinedo has published more than 600 research articles in international medical journals. He is the founder of the VUmc Cancer Center Amsterdam.
The presentation of the David A. Karnofsky Memorial Award will take place during the Opening Session of the 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO), which brings together more than 25,000 oncology professionals from a broad range of specialties, on Saturday, May 31, 2014, 9:30 AM, in Chicago, Il, USA
Attendees of the 2014 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. This year the theme of the Meeting is “Science and Society.”
For more information
[1] ASCO website: http://tinyurl.com/mmbrgga
